← Insider buys

Michael R Winter has bought stock on 3 days since May 2019

Director at Allient Inc., and 1 other company

SEC CIK 0001612951 · Filings on SEC.gov ↗

$147KBought
$49KSold
Sep 23Last buy

Michael R Winter's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

4 filings since May 2019, newest first

About Michael R Winter

Michael R. Winter, CPA, is an independent director at Allient Inc. (ALNT), where he has served since 2014. As Chair of the Audit Committee and a member of the Governance & Nominating Committee, he is designated as an "audit committee financial expert" under SEC rules, leveraging his extensive expertise in financial reporting, internal controls, and compliance. Winter, age 71, recently engaged in insider trading activities at Allient Inc. as a director, reflecting his ongoing commitment to the company's governance.

Winter brings over 25 years of experience as a partner at PricewaterhouseCoopers LLP (PwC), based in the Buffalo office with National Office involvement in New Jersey from 2010 to 2014. There, he led assurance services for public entities, specializing in financial statement preparation and analysis. Previously, he served as a director at Gas Natural, Inc. from 2014 to 2017 until its sale, and currently holds a director position at Catholic Health System in Western New York, contributing to its Finance & Operations and Strategic Planning Committees. His career highlights include strong board attendance, equity ownership exceeding company guidelines (approximately 32,335 beneficial shares as of recent records), and alignment through time-based stock awards.

Winter holds a B.S. in Accounting from SUNY Binghamton and an MBA in Management & Finance from Canisius College. He also completed the Directors’ Consortium Program at Stanford Graduate School of Business, enhancing his governance acumen. His independent status under Nasdaq standards and technical oversight make him a key figure in Allient's board effectiveness.

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.